WAWalid Ahmed Alkeridy

Walid Ahmed Alkeridy

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Walid Ahmed Alkeridy has a total of 254 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    SARS-CoV-2 infection, myelin, and cognition in middle-aged and older adults: The CLSA COVID-19 Brain Health Study

    by Nárlon C Boa Sorte Silva, Ryan G Stein, Yi Gu, Chun Liang Hsu, Roger C Tam, Marina Salluzzi, Cheryl R McCreary, Walid A Alkeridy, Kevin Lam, Alex MacKay, et al.

    Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the cause of COVID-19, has been hypothesized to contribute to cognitive decline through effects on myelin. We investigated SARS-CoV-2 infection effects on myelin and cognition in middle-aged and older adults. We analyzed cross-sectional MRI and cognitive data from the Canadian Longitudinal Study on Aging COVID-19 Brain Health Study. We quantified cerebral white matter myelin using myelin water imaging. Cognition included modified Rey Auditory Verbal Learning Test, Mental Alternation Test, and verbal fluency via animal fluency. Analysis of covariance were perfomed to determine differences between SARS-CoV-2 cases and controls adjusting for relevant confounding factors. Exploratory moderation analyses assessed the influence of biological sex, APOE ε4 status, and COVID-19-related symptom incidence and severity. We included 352 community-dwelling individuals with infection status determined at time of MRI scanning (SARS-CoV-2 cases, n = 64; controls, n = 288). Participant mean (SD) age was 65.3 (8.4) years, and 50.3% were female. There were no differences between SARS-CoV-2 cases and controls in myelin content or objective measures of cognition. There were no moderating effects of sex or APOE ε4 status. Cases showed greater incidence (P<0.001) and severity (P<0.001) of COVID-19-related symptoms. Moderation analysis of myelin content revealed significant interactions between symptom incidence and severity with diagnosis group after correcting for multiple comparisons (P corrected < 0.05). Post hoc analysis showed that symptom incidence and severity were inversely associated with myelin content in SARS-CoV-2 cases but not in controls across multiple regions-of-interest. SARS-CoV-2 cases and controls did not differ in myelin content or cognition. Among cases, greater self-reported symptom incidence and severity were associated with lower myelin content, an exploratory finding that requires longitudinal confirmation before it can be interpreted as infection-related myelin loss.

  • Open Access

    Unseen barriers to home healthcare: a qualitative study of providers’ perspectives from Saudi Arabia

    by Khulud K. Alharbi, Walid A. Alkeridy, Nawal A Sindi, Rana A. Alhelali, Samah H. Hajjar, Tassnym H. Sinky

    This study investigated the challenges of providing care in Home Health Care (HHC) settings in Saudi Arabia. We employed a qualitative design and used them

  • Open Access

    Exercise and white matter hyperintensities: a randomized clinical trial

    by Nárlon C Boa Sorte Silva, Roger C Tam, Walid A Alkeridy, Kevin Lam, Elizabeth Dao, Cindy K Barha, Ryan S Falck, Chun Liang Hsu, Ging-Yuek Robin Hsiung, Ken M Madden, et al.

    Subcortical vascular cognitive impairment (SVCI) is a risk factor for dementia. White matter hyperintensity (WMH) lesions are considered a hallmark of SVCI. We investigated the impact of progressive resistance exercise training (RT) on WMH in individuals with SVCI. This 12-month, single-blinded, proof-of-concept randomized clinical trial involved 89 community-dwelling individuals aged 55 years or older living with SVCI. Participants were randomized (1:1 ratio) to twice-weekly (60 min/day) RT (n = 44) or a balance and tone (BAT, n = 45) control intervention. Whole-brain and region-specific WMH volumes were measured using T2- and proton density-weighted magnetic resonance imaging. Group differences in the 12-month change in WMH from baseline were determined via analysis of covariance, adjusting for baseline WMH, intracranial volume, age, sex and training format (remote versus in-person). Exploratory analyses tested associations between changes in WMH and changes in growth factors. Participants were mostly females (n = 58, 65.17%) with an average of 74.50 (SD 5.71) years. There were no differences between groups in whole-brain WMH volume after 12 months [estimated mean difference (95% CI): −0.016 (−0.052 to 0.019) log-transformed cm3, P = 0.364]. Region-specific analysis showed main effects of training on WMH volume in the temporal lobe [−0.115 (−0.207 to −0.023), P = 0.015] and splenium of the corpus callosum [−0.120 (−0.215 to −0.025), P = 0.014], favouring the RT group. There was a significant group-by-sex interaction, indicating that intervention effects varied by sex [estimated mean difference-of-differences (95% CI) = −0.093 (−0.170 to −0.016), P = 0.019]. Post hoc contrasts showed that RT (versus BAT) significantly reduced whole-brain WMH volume in female [−0.049 (−0.093 to −0.005), P = 0.029] but not male [0.044 (−0.017 to 0.105), P = 0.152] participants. Exploratory analysis showed that increasing levels of vascular endothelial growth factor [standardized β (95% CI) = −0.503 (−0.838 to −0.167), P = 0.004] were associated with a reduction in whole-brain WMH volume. No associations between insulin-like growth factor 1 and WMH volumes were found (all P > 0.05). Based on these findings, we conclude that progressive RT may reduce WMH progression in community-dwelling individuals living with SVCI. This trial is registered with ClinicalTrials.gov, number NCT02669394; submitted for registration on 1 February 2016; the first patient enrolment was on 26 May 2016.

  • Open Access

    Risk factors and locations of falls among older pilgrims during Hajj: Implications for targeted prevention

    by Walid A. Alkeridy, Khulud K. Alharbi, Shahad M. Sofi, Bashaier D. Alosaimi, Abrar M. Aljohani, Basmah A. Rafie, Bashaier A. Fairaq, Gehan K. Mubaraki, Nawal A. Sindi, Maha M. Almarwani


  • Open Access

    Goals of care discussions among critically Ill patients on vasopressor treatment

    by Walid A. Alkeridy, Khalid M. Alayed, Shadan AlMuhaidib, Mohammed Khalid Alageel, Sarah Ahmed Alqahtani, Shatha Bin Dher, Abdulaziz M Almotairi, Claire Ann Lim, Musa F. Alzahrani

    Background: Goals of care (GOC) discussions are essential for aligning medical management with the values of critically ill patients, particularly those requiring vasopressors, such as dopamine. To evaluate GOC discussions in terms of prevalence, factors associated with documentation, and impact on survival among critically ill patients requiring vasopressors for hemodynamic support. Methods: We conducted a retrospective cohort study at a tertiary healthcare facility in Riyadh, Saudi Arabia, focusing on patients admitted to intensive care units (ICUs) and internal medicine (IM) wards. The study included adult in patients who received dopamine during their hospital stay. Factors associated with GOC documentation were identified using logistic regression analysis. The 30-day and 1-year survival rates according to GOC discussions were analyzed using Kaplan–Meier survival curves, which were compared using the log-rank test. Results: Of 301 patients, 56.8% were men and 64.8% were aged ≥60 years. GOC discussions were documented in 61.8% of patients and were more frequent among older patients (≥60 years) than among younger patients (73.1% vs. 51.3%, p < 0.001) and in those with higher APACHE II scores (median 21.0 vs. 18.0, p = 0.001). Multivariable analysis identified age ≥ 60 years as independent precipitating factor of GOC discussions (odds ratio 2.41, 95% confidence interval 1.34–4.32, p = 0.003). The study found significantly lower survival rates at both 30 days and 1 year among patients who had documented GOC discussions. Conclusions: GOCs were more prevalent among critically ill older patients. The study found significantly higher mortality rates at both 30 days and 1 year among patients who had documented GOC discussions. These findings highlight the need for institutional strategies to integrate GOC discussions into routine care and address their potential implications on patient outcomes.


  • Open Access

    Determinants of Vaccine Hesitancy among Home Health Care Service Recipients in Saudi Arabia

    by Walid A. Alkeridy, Hisham Alquaydheb, Shadan Almuhaidib, Nawal A. Sindi, Arwa Aljasser, Janet Kushner Kow, Amani S. Alqahtani

    Background: Vaccine hesitancy has been identified by the World Health Organization (WHO) as a major worldwide health threat. Home Health Care (HHC) service recipients represent a vulnerable group and were prioritized to receive coronavirus disease (COVID-19) vaccination during the national vaccine campaigns in Saudi Arabia. We aimed to investigate the most frequent reasons for vaccine hesitancy among home health care recipients in Saudi Arabia. Methods: This cross-sectional survey was conducted among home health care (HHC) service recipients in Saudi Arabia from February 2022 to September 2022. The behavioral and social drivers (BeSD) model developed by the WHO was used to understand the factors affecting vaccination decision making in our cohort. Results: Of the 426 HHC service recipients enrolled in the study, a third were hesitant to complete the COVID-19 vaccination series. The most prevalent reported reason for COVID-19 vaccine refusal was concerns about the vaccine side effects (41.6%). Factors independently associated with COVID-19 vaccination hesitancy were: having chronic conditions (odds ratio [OR] = 2.59; 95% confidence interval [CI] = 1.33–5.05, p = 0.005), previous COVID-19 diagnosis (OR = 0.48; 95% CI: 0.28–0.82, p = 0.008), ease of getting the COVID-19 vaccine by themselves (OR = 0.49; 95% CI: 0.28–0.89, p = 0.018), belief in the importance of COVID-19 vaccine in protecting their health (OR = 0.60; 95% CI: 0.38–0.96, p = 0.032), and confidence in the safety of COVID-19 vaccination (OR = 0.38; 95% CI: 0.21–0.69, p = 0.001). Conclusion: Only one-third of the study participants were hesitant to complete the series of COVID-19 vaccination. Understanding the factors underpinning vaccine hesitancy among this group would help healthcare workers and policymakers in developing personalized health awareness campaigns aimed at improving vaccine acceptance levels.


  • Open Access

    Predictors of Mortality in Home Health Care Service: Data from Saudi Arabia

    by Walid A Alkeridy, Arwa Aljasser, Khalid Mohammed Alayed, Saad M Alsaad, Amani S Alqahtani, Claire Ann Lim, Sultan H Alamri, Doaa Zainhom Mekkawy, Mohammed Al-Sofiani

    Objective: This study aimed to 1) report the prevalence of chronic conditions among Saudi people receiving long-term home health care (HHC) services, 2) identify the predictors of mortality among individuals receiving long-term HHC services, and 3) study the association between frailty and poor health outcomes among HHC users. Design: Retrospective cross-sectional descriptive study. Setting and Participants: A total of 555 participants were recruited from HHC services at King Saud University Medical City (KSUMC), Riyadh, Saudi Arabia. We collected the data from electronic health records (EHR), patient charts, and caregiver interviews for 555 participants included in HHC program from the year 2019 to 2022. Methods: Only individuals fulfilling the HHC program’s eligibility criteria were included to the study. A total of 555 participants were included in the analysis. We assessed the functional performance by the Katz activity of daily living and Bristol Activity of Daily Living Scale (BADLS). A trained health care provider assessed frailty using the Clinical Frailty Scale (CFS). We calculated the means and frequency to describe the prevalence of chronic conditions and variables of interest. A Chi-square test or independent-samples t-test was run to determine if there were differences between the alive and deceased individuals. A binary logistic regression model was performed to predict mortality of HHC service recipients. Results: The mean age for deceased individuals in HHC was 78.3 years. Over twenty percent of individuals receiving HHC services were readmitted to the hospital. We found that the strongest predictors for mortality were pressure ulcers with an odds ratio of 3.75 and p-value of < 0.0001, and the Clinical Frailty Scale, which had an odds ratio of 1.69 and p-value of 0.002, using multivariate regression analysis. Conclusions and Implications: In conclusion, our study found that pressure ulcers and frailty are the strongest predictors of mortality for individuals receiving home health care services.


  • Myelin Content and Gait Impairment in Older Adults with Cerebral Small Vessel Disease and Mild Cognitive Impairment

    by Nárlon C Boa Sorte Silva, Elizabeth Dao, Chun Liang Hsu, Roger C Tam, Ryan Stein, Walid Alkeridy, Cornelia Laule, Irene M Vavasour, Teresa Liu-Ambrose


  • Open Access

    Prognostic indicators and outcomes of hospitalised COVID-19 patients with neurological disease: An individual patient data meta-analysis

    by Bhagteshwar Singh, Suzannah Lant, Sofia Cividini, Jonathan W. S. Cattrall, Lynsey C. Goodwin, Laura Benjamin, Benedict D. Michael, Ayaz Khawaja, Aline de Moura Brasil Matos, Walid Alkeridy, et al.

    Background: Neurological COVID-19 disease has been reported widely, but published studies often lack information on neurological outcomes and prognostic risk factors. We aimed to describe the spectrum of neurological disease in hospitalised COVID-19 patients; characterise clinical outcomes; and investigate factors associated with a poor outcome. Methods: We conducted an individual patient data (IPD) meta-analysis of hospitalised patients with neurological COVID-19 disease, using standard case definitions. We invited authors of studies from the first pandemic wave, plus clinicians in the Global COVID-Neuro Network with unpublished data, to contribute. We analysed features associated with poor outcome (moderate to severe disability or death, 3 to 6 on the modified Rankin Scale) using multivariable models. Results: We included 83 studies (31 unpublished) providing IPD for 1979 patients with COVID-19 and acute new-onset neurological disease. Encephalopathy (978 [49%] patients) and cerebrovascular events (506 [26%]) were the most common diagnoses. Respiratory and systemic symptoms preceded neurological features in 93% of patients; one third developed neurological disease after hospital admission. A poor outcome was more common in patients with cerebrovascular events (76% [95% CI 67–82]), than encephalopathy (54% [42–65]). Intensive care use was high (38% [35–41]) overall, and also greater in the cerebrovascular patients. In the cerebrovascular, but not encephalopathic patients, risk factors for poor outcome included breathlessness on admission and elevated D-dimer. Overall, 30-day mortality was 30% [27–32]. The hazard of death was comparatively lower for patients in the WHO European region. Interpretation: Neurological COVID-19 disease poses a considerable burden in terms of disease outcomes and use of hospital resources from prolonged intensive care and inpatient admission; preliminary data suggest these may differ according to WHO regions and country income levels. The different risk factors for encephalopathy and stroke suggest different disease mechanisms which may be amenable to intervention, especially in those who develop neurological symptoms after hospital admission.


  • Mind the gaps: functional networks disrupted by white matter hyperintensities are associated with greater falls risk

    by Rachel A. Crockett, Chun Liang Hsu, Elizabeth Dao, Roger Tam, Walid Alkeridy, Janice J. Eng, Todd C. Handy, Teresa Liu-Ambrose